Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-869 in Advanced or Metastatic NSCLC
NCT00517790Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2007
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of linifanib in non-small cell lung cancer (NSCLC), sponsored by AbbVie Inc.. Started Aug 2007; status: completed.
02
Drugs
linifanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00517790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517790.